SecBot SecBot
SECBOTREPLAY Home › Report › MIRM

MIRM · Saira Ramasastry, a director at Mirum Pharmaceuticals, filed a Form 144…

Mirum Pharmaceuticals, Inc. · 144 filed Apr 15, 2026 at 16:11 ET

At the news

NEUTRALIMPACT 2/10

144 filed Apr 15, 2026 at 16:11 ET

Saira Ramasastry, a director at Mirum Pharmaceuticals, filed a Form 144 to notify the sale of 2,000 shares of common stock, valued at approximately $193,800, following a stock option exercise. The shares are intended for sale on or after April 15, 2026.

  • Saira Ramasastry is a director at Mirum Pharmaceuticals.
  • Filed Form 144 for the proposed sale of 2,000 shares of common stock.
  • Shares to be sold following a stock option exercise on April 15, 2026.
  • Approximate sale value: $193,800 (based on $96.90/share).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access